PERSONALIZED PHARMACOLOGICAL CORRECTION OF IMMUNE SYSTEMS, METABOLIC AND NEUROPSYCHIC PARAMETERS IN CHRONIC BRAIN ISCHEMIA OF STAGE I AND II ON THE BACKGROUND OF HYPERTENSION DISEASE

The study aimed to develop a personalized pharmacological correction of immune, metabolic and neuropsychiatric disorders in chronic cerebral ischemia (CCI) stages I and II. The study included 104 patients, of which 76 were female and 28 were male, with CCI on the background of grade II hypertension,...

Celý popis

Podrobná bibliografie

Hlavní autoři:	A. I. Konoplya, A. A. Shulginova, N. A. Bystrova, V. P. Gavrilyuk, G. N. Ryzhikova
Médium:	Artigo
Jazyk:	Russo
Vydáno:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2021-10-01
Edice:	Медицинская иммунология
Témata:	chronic cerebral ischemia personalized pharmacological correction of immunometabolic disorders
On-line přístup:	https://www.mimmun.ru/mimmun/article/view/1988
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!